# Nuclide record f-18-florbetapir (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-florbetapir/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-florbetapir" ;
  schema:name "Florbetapir F-18"@en ;
  schema:alternateName "Amyvid"@en, "18F-AV-45"@en, "Amyvid" ;
  schema:description "A PET scan tracer that shows whether a patient's brain contains the sticky amyloid protein clumps linked to Alzheimer's disease, and whether they qualify for amyloid-lowering drugs."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-florbetapir/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202008s046lbl.pdf>, <https://investor.lilly.com/news-releases/news-release-details/fda-approves-updated-label-lillys-amyvid-florbetapir-f-18>, <https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=308>, <https://jnm.snmjournals.org/content/early/2025/01/07/jnumed.124.268756> ;
  nuclide:status "approved" ;
  nuclide:tag "amyloid PET", "diagnostic", "neurology" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 2012: PET imaging of the brain to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment being evaluated for AD and other causes of cognitive decline", "US 2025: Label update adding selection of patients indicated for amyloid beta-directed therapy" ;
  nuclide:related <https://nuclide.cc/indications/alzheimers-disease/>, <https://nuclide.cc/drugs/f-18-flutemetamol/>, <https://nuclide.cc/drugs/f-18-florbetaben/>, <https://nuclide.cc/drugs/f-18-flortaucipir/>, <https://nuclide.cc/companies/eli-lilly/>, <https://nuclide.cc/isotopes/f-18/> .